PYC.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia...

Stats
Today's Volume	564 511
Average Volume	1.73M
Market Cap	415.48M
EPS	$0 ( 2024-02-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.30
ATR14	$0.00100 (1.11%)

PYC Therapeutics Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PYC Therapeutics Ltd Financials

Annual	2023
Revenue:	$15.81M
Gross Profit:	$14.92M (94.42 %)
EPS:	$-0.00700

Q2	2023
Revenue:	$0
Gross Profit:	$-336 421 (0.00 %)
EPS:	$-0.00400

Q4	2023
Revenue:	$12.33M
Gross Profit:	$12.24M (99.24 %)
EPS:	$-0.00200

Q3	2022
Revenue:	$6.17M
Gross Profit:	$6.17M (100.00 %)
EPS:	$-0.00100

Financial Reports:

No articles found.

PYC Therapeutics Ltd

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.